Novel approaches to the development of tyrosine kinase inhibitors and their role in the fight against cancer

ISSN： 1746-0441

Source： Expert Opinion on Drug Discovery, Vol.9, Iss.1, 2014-01, pp. : 77-92

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Novel Tyrosine Kinase Inhibitors in the Treatment of Cancer

Current Drug Targets, Vol. 10, Iss. 6, 2009-06 ,pp. : 575-576

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacoinformatic Approaches to Design Novel Inhibitors of Protein Kinase B Pathways in Cancer

Current Cancer Drug Targets, Vol. 18, Iss. 9, 2018-11 ,pp. : 830-846

Bentham Science Publishers

Access to resources Recommend Favorite

Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: Current Status and Future Perspectives in the Development of Novel Irreversible Inhibitors for the Treatment of Mutant Non-small Cell Lung Cancer

Current Pharmaceutical Design, Vol. 19, Iss. 5, 2013-02 ,pp. : 818-832

Bentham Science Publishers

Access to resources Recommend Favorite

Tyrosine kinase inhibitors as novel drugs for the treatment of diabetes

By Prada Patricia O

Expert Opinion on Investigational Drugs, Vol. 22, Iss. 6, 2013-09 ,pp. : 751-763

Informa Healthcare

Access to resources Recommend Favorite

Novel FLT3 tyrosine kinase inhibitors

By Levis Mark Small Donald

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 12, 2003-12 ,pp. : 1951-1962

Informa Healthcare

Access to resources Recommend Favorite